Literature DB >> 7024719

Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.

M Neufeld, N K Maclaren, R M Blizzard.   

Abstract

A review of 295 patients with autoimmune Addison's disease which occurred as part of a polyglandular autoimmune syndrome is presented. Information of 41 cases was obtained from our clinics and from the examination of medical records, while 254 cases were culled from the literature. We report that autoimmune Addison's disease in association with other autoimmune diseases occurs in at least two distinct types. Addison's disease occurring in Type I polyglandular autoimmune disease (PGA) is associated with chronic mucocutaneous candidiasis and/or acquired hypoparathyroidism. The age of onset is predominately in childhood or in the early adult years. Type I PGA syndrome is also frequently associated with chronic active hepatitis, malabsorption, juvenile onset pernicious anemia, alopecia and primary hypogonadism. Insulin requiring diabetes and/or autoimmune thyroid disease are infrequent. In contrast, Addison's disease in Type II PGA is associated with insulin requiring diabetes and/or autoimmune thyroid disease(s). Although the age of onset of Addison's disease in Type II PGA syndrome is not confined to any age group or any specific sex, it occurs predominately in the middle years of life in females. The associated autoimmune diseases found in Type I disease, such as chronic active hepatitis, etc. (see table II) are rare in Type II PGA disease except for a low frequency of gonadal failure. We provide evidence to support the concept that the Addison's diseases in Type I and II PGA syndromes have different genetic bases, as related to HLA haplotypes, and possibly have different underlying pathogeneses.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024719     DOI: 10.1097/00005792-198109000-00003

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  76 in total

Review 1.  Xenobiotic-metabolizing enzymes as autoantigens in human autoimmune disorders. An update.

Authors:  E Boitier; P Beaune
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 2.  Autoimmune polyglandular syndrome type 1.

Authors:  P Obermayer-Straub; C P Strassburg; M P Manns
Journal:  Clin Rev Allergy Immunol       Date:  2000-04       Impact factor: 8.667

Review 3.  Polyspecificity of autoimmune responses in type 1 (autoimmune) diabetes.

Authors:  L M Esteban; A G Baxter
Journal:  Clin Exp Immunol       Date:  2001-11       Impact factor: 4.330

Review 4.  Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy (APECED): a model disease to study molecular aspects of endocrine autoimmunity.

Authors:  P Peterson; J Pitkänen; N Sillanpää; K Krohn
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

5.  [Optic neuropathy in Schmidt-Carpenter syndrome].

Authors:  P C Horn; J Harder; C P Lohmann; I Lanzl
Journal:  Ophthalmologe       Date:  2010-07       Impact factor: 1.059

6.  Schimidt Syndrome: An Unusual Cause of Hypercalcaemia.

Authors:  Nisha Jose; George Prashanth Kurian
Journal:  J Clin Diagn Res       Date:  2016-05-01

7.  Predicting the onset of Addison's disease: ACTH, renin, cortisol and 21-hydroxylase autoantibodies.

Authors:  Peter R Baker; Priyaanka Nanduri; Peter A Gottlieb; Liping Yu; Georgeanna J Klingensmith; George S Eisenbarth; Jennifer M Barker
Journal:  Clin Endocrinol (Oxf)       Date:  2012-05       Impact factor: 3.478

Review 8.  [Adrenal crisis. Diagnostic and therapeutic management of acute adrenal cortex insufficiency].

Authors:  S Hahner; W Arlt; B Allolio
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

9.  The dysplastic naevus syndrome and endocrine disease.

Authors:  S J Adams; M H Rustin; T W Robinson; D D Munro
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-16

10.  Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism.

Authors:  M L Brandi; G D Aurbach; A Fattorossi; R Quarto; S J Marx; L A Fitzpatrick
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.